Showing results (11-20 of 154) with videos related to
Sort By:
Pageof 16
Current Treatment Options in Rheumatology|September 21, 2019
Pharmacotherapy Options in the Management of Raynaud's PhenomenonAlicia M Hinze, Fredrick M WigleyCleveland Clinic Journal of Medicine|October 7, 2017
Treating Raynaud phenomenon: Beyond staying warmSamantha C Shapiro, Fredrick M WigleyExpert Opinion on Investigational Drugs|February 28, 2003
Treatment of scleroderma: an updateSangeeta D Sule, Fredrick M WigleyMayo Clinic Proceedings|April 2, 2013
My approach to the treatment of sclerodermaAmi A Shah, Fredrick M WigleyExpert Opinion on Investigational Drugs|November 23, 2013
Novel investigational agents for the treatment of sclerodermaZsuzsanna Hortobagyi McMahan, Fredrick M WigleyRheumatic Diseases Clinics of North America|March 11, 2008
Often forgotten manifestations of systemic sclerosisAmi A Shah, Fredrick M WigleyArthritis Care & Research|August 30, 2020
Measurement of Minimal Disease Activity in Psoriatic Arthritis Using the Patient-Reported Outcomes Measurement Information System-Physical Function or the Health Assessment Questionnaire Disability IndexErin Chew, Jamie Perin, Thomas Grader-Beck, et al.The Journal of Rheumatology|June 5, 2003
Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosisMegan E B Clowse, Fredrick M WigleyMedicine|January 22, 2008
Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG)Marissa Blum, Fredrick M Wigley, Laura K HummersBMC Gastroenterology|April 16, 2021
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosisEric J Dein, Fredrick M Wigley, Zsuzsanna H McMahanPageof 16